Home › Crohn's Disease › Virginia › Roanoke
Crohn's Disease clinical trials in Roanoke, VA
4 studies for Crohn's Disease are looking for participants at sites in and around Roanoke (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
RecruitingPhase 4
- Gastroenterology Consultants of Southwest Virginia., Roanoke
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
RecruitingPhase 3
- Carilion Children's Tanglewood Center, Roanoke
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
RecruitingPhase 3
- Carilion Children's Tanglewood Center, Roanoke
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
RecruitingPhase 2
- Gastroenterology Consultants of Southwest Virginia., Roanoke
About Crohn's Disease
Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.
More about Crohn's Disease on MedlinePlus
Crohn's Disease trials in other cities
- New York City, NY35 studies
- Cleveland, OH19 studies
- St. Louis, MO19 studies
- Boston, MA19 studies
- Miami, FL19 studies
- Orlando, FL17 studies
- Houston, TX17 studies
- Atlanta, GA17 studies
- Tyler, TX16 studies
- San Diego, CA15 studies
- San Antonio, TX15 studies
- Los Angeles, CA15 studies
Other studies in Roanoke
- Colorectal Cancer10 studies
- Heart Failure9 studies
- Non-Small Cell Lung Cancer8 studies
- Prostate Cancer7 studies
- Breast Cancer7 studies
- Metastatic Cancer6 studies
- Diabetic Foot5 studies
- Ovarian Cancer4 studies
- Stomach Cancer4 studies
- Melanoma4 studies
- Ulcerative Colitis4 studies
- Small Cell Lung Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.